http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011101624-B4
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate | 2011-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2012-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fa45a4e7fa25bf21eba8ee4db301e4a |
publicationDate | 2012-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2011101624-B4 |
titleOfInvention | Method for treating intraocular neovascular diseases |
abstract | A method is provided for administering to a mammal suffering from, or at risk for, an intraocular neovascular disorder with regular dosing of a therapeutically effective amount of VEGF antagonist, followed by less frequent dosing of a therapeutically s effective amount of VEGF antagonist. 301061_1 (GHMttes) P71763 AU2 0-0DooII |
priorityDate | 2004-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 519.